LABP - Landos Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $38.75. This is a potential upside of $15.82 (68.99%) from yesterday's end of day stock price of $22.93.

Landos Biopharma's activity chart (see below) currently has 7 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 154.5 days.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 06-Jan-2023. First documented stock forecast 01-Mar-2021.

Best performing analysts who are covering LABP - Landos Biopharma:

Reuben Garner Jessica Fye Steven Seedhouse Chris Howerton Thomas Smith Prakhar Agrawal

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$14

2 years 24 days ago
(06-Jan-2023)

1/2 (50%)

$2 (16.67%)

713

Hold

$3

2 years 2 months 19 days ago
(11-Nov-2022)

1/3 (33.33%)

$-7.6 (-71.70%)

87

Buy

2 years 5 months 18 days ago
(12-Aug-2022)

0/1 (0%)

$167.4 (102.95%)

Hold

$15

$8.43 (128.31%)

$170

3 years 27 days ago
(03-Jan-2022)

1/2 (50%)

$-37.2 (-71.26%)

64

Buy

$45

$41.62 (1231.36%)

$45

3 years 2 months 12 days ago
(18-Nov-2021)

2/2 (100%)

$-53.8 (-54.45%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LABP (Landos Biopharma) average time for price targets to be met?

On average it took 154.5 days on average for the stock forecasts to be realized with a an average price target met ratio 38.89

Which analyst has the current highest performing score on LABP (Landos Biopharma) with a proven track record?

REUBEN GARNER

Which analyst has the current lower performing score on LABP (Landos Biopharma) with a proven track record?

PRAKHAR AGRAWAL

Which analyst has the most public recommendations on LABP (Landos Biopharma)?

Reuben Garner works at BENCHMARK and has 14 price targets and 8 ratings on LABP

Which analyst is the currently most bullish on LABP (Landos Biopharma)?

Reuben Garner with highest potential upside - $41.62

Which analyst is the currently most reserved on LABP (Landos Biopharma)?

Steven Seedhouse with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?